作者:
Blijlevens,N. [1]
;
DeChateau,M. [2]
;
Krivan,G. [3]
;
Rabitsch,W. [4]
;
Szomor,A. [5]
;
Pytlik,R. [6]
;
Lissmats,A. [7]
;
Johnsen,H.E. [8]
;
DeWitte,T. [9]
;
Einsele,H. [10]
;
Ruutu,T. [11]
;
Niederwieser,D.
作者单位:
First Department of Medicine, University Hospital Pecs, Pecs, Hungary
[1]
University Hospital, Praha, Czech Republic
[2]
Medizinische Klinik II, Wurzburg, Germany
[3]
University Hospital, Helsinki, Finland
[4]
Department of Haematology, Radboud University Nijmegen Medical Centre, Nijmegen, PO Box 9101
[5]
Department of Internal Medicine i, Bone Marrow Transplantation Unit, Medical University of Vienna
[6]
Clinical Development, Swedish Orphan Biovitrum AB, Stockholm, Sweden
[7]
Department of Tumorimmunology, Radboud University Nijmegen Medical Centre, Nijmegen, Nijmegen
[8]
St Laszlo Hospital, Budapest, Hungary
[9]
Department of Haematology, Aalborg Hospital Science and Innovation Centre, Aalborg Hospital
[10]
Department of Hematology/Oncology, University of Leipzig, Leipzig, Germany
[11]
发布时间
2013-11-20